This population is characterized by CD3+ T cells with or without the acquisition of CD56+ and by CD3-CD56+ NK cells, together combining a highly proliferative and cytotoxic cell population against a broad spectrum of cancers [143,144,145]. This evidence concerns the gene NCAM1 and cancer.